Spectrum Pharmaceuticals, Inc. Reports Financial Results For First Quarter 2014
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.